Sirolimus for Injection (Albumin Bound) Combined With Octreotide Long-acting Injection in Patients With Metastatic Gastroenteropancreatic Neuroendocrine Tumors

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Gastroenteropancreatic Neuroendocrine Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Chinese PLA General Hospital, Beijing, Beijing Municipality, China

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

GEP-NET · Gastroenteropancreatic Neuroendocrine Tumor · Gastroenteropancreatic Neuroendocrine Tumor Disease

Abroad (travel likely)RecruitingPHASE3

Phoenix, United States · Duarte, United States

A Study of Treatment Patterns and Outcomes in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET) Patients

Gastroenteropancreatic Neuroendocrine Tumor

Abroad (travel likely)Recruiting

East Hanover, United States

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

Neuroendocrine Tumors Unresectable · Neuroendocrine Tumor Metastatic · Gastroenteropancreatic Neuroendocrine Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Jacksonville, United States · Miami, United States

Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors

Neuroendocrine Tumors · Gastroenteropancreatic Neuroendocrine Tumor

Abroad (travel likely)Recruiting

Dallas, United States · Dallas, United States